Metsera calls Pfizer threats ‘nonsense’ as rift widens between companiesnews2025-11-03T16:46:46+00:00November 3rd, 2025|Endpoints News|
Kimberly-Clark inks $40B+ deal for Kenvuenews2025-11-03T13:52:55+00:00November 3rd, 2025|Endpoints News|
Roche, Manifold Bio to advance new brain shuttles in pact worth up to $2B+news2025-11-03T11:45:30+00:00November 3rd, 2025|Endpoints News|
What would Metsera bring to Novo Nordisk?news2025-10-31T11:32:14+00:00October 31st, 2025|Endpoints News|
Novo’s Metsera offer could pose a test for Trump’s FTCnews2025-10-30T19:50:23+00:00October 30th, 2025|Endpoints News|
Lilly CEO expects more ‘noise’ as Metsera M&A fight beginsnews2025-10-30T19:32:53+00:00October 30th, 2025|Endpoints News|
Post-Hoc Live: Breaking down the M&A drama between Pfizer, Metsera and Novonews2025-10-30T17:06:04+00:00October 30th, 2025|Endpoints News|
The showdown over Metsera: Pfizer and Novo prepare for a bidding warnews2025-10-30T15:20:13+00:00October 30th, 2025|Endpoints News|
Novo Nordisk proposes to acquire Metsera in bid to disrupt Pfizer’s dealnews2025-10-30T10:16:25+00:00October 30th, 2025|Endpoints News|
Roche promises $1B to China biotech for preclinical COPD bispecificnews2025-10-30T01:48:30+00:00October 30th, 2025|Endpoints News|
